Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vd vs Vcd in Relapsed/Refractory Multiple Myeloma
NCT00813150Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide in multiple myeloma (MM), sponsored by Janssen Pharmaceutical. Started Jan 2009; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00813150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813150.